Terminated PHASE1 INTERVENTIONAL NCT00252434

Behavioral Therapy Development for Methamphetamine Abuse

Sponsor: University of California, Los Angeles

Conditions Depression Drug Abuse Sexually Transmitted Diseases

Interventions Cognitive Behavioral Therapy Development for Methamphetamine Abuse

Updated 5 times since 2017 Last updated: Jan 26, 2016 Started: Aug 31, 2004 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow enrollment

Other terminated trials from University of California, Los Angeles

See all terminations from University of California, Los Angeles

Other Depression trials with similar outcome

Browse all Depression trials

Listed as NCT00252434, this PHASE1 trial focuses on Depression and Drug Abuse and remains terminated or withdrawn. Sponsored by University of California, Los Angeles, it has been updated 5 times since 2004, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States